Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately. (See "Society guideline links: Immune thrombocytopenia (ITP) and other platelet disorders" and "Society guideline links: von Willebrand disease" and "Society guideline links: Rare inherited bleeding disorders" and "Society guideline links: Hemophilia A and B".)
International
●AABB: Evidence-based practice guidelines for plasma transfusion (2010)
●International recommendations on the diagnosis and treatment of patients with acquired hemophilia A (2009)
Canada
●National Advisory Committee on Blood and Blood Products (NAC): Immunoglobulin utilization statement (2021)
●NAC: Statement on fibrinogen concentrate use in acquired hypofibrinogenemia (2021)
United States
●Choosing Wisely: Don't use bleeding time test to guide patient care (2013)
United Kingdom
Australia-New Zealand
Japan
●[In Japanese] Japanese Society on Thrombosis and Hemostasis (JSTH): Clinical practice guidelines on acquired hemophilia A, revised edition (2017)